SCHEMBL10605039

SCHEMBL10605039

C#C[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SHBG P04278 7/20 0.71
▸ LMNA P02545 7/20 0.71
▸ SMN1; SMN2 Q16637 7/20 0.71
▸ TSHR P16473 5/20 0.71
▸ NR3C1 P04150 4/20 0.71
▸ CYP2C19 P33261 4/20 0.71
▸ HIF1A Q16665 4/20 0.71
▸ MEN1 O00255 3/20 0.71
▸ KMT2A Q03164 3/20 0.71
▸ PGR P06401 3/20 0.71
▸ AR P10275 2/20 0.71
▸ THRB P10828 1/20 0.71
▸ ESR1 P03372 1/20 0.71
▸ SERPINA6 P08185 6/20 0.69
▸ BLM P54132 4/20 0.69
▸ MAPT P10636 3/20 0.69
▸ ADORA3 P0DMS8 2/20 0.69
▸ MAPK3 P27361 1/20 0.69
▸ SLC6A3 Q01959 1/20 0.69
▸ ALDH1A1 P00352 5/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10605063 0.84 CYP19A1 (0.60) SHBGLMNASMN1; SMN2TSHRNR3C1
Ethisterone SCHEMBL11152514 0.84 LMNA (0.92) SHBGLMNASMN1; SMN2TSHRNR3C1
Ethisterone SCHEMBL12417537 0.83 LMNA (1.00) SHBGLMNASMN1; SMN2TSHRNR3C1
Ethisterone SCHEMBL24475 0.83 LMNA (1.00) SHBGLMNASMN1; SMN2TSHRNR3C1
Ethisterone SCHEMBL7604035 0.83 LMNA (1.00) SHBGLMNASMN1; SMN2TSHRNR3C1
Ethisterone SCHEMBL780055 0.83 LMNA (1.00) SHBGLMNASMN1; SMN2TSHRNR3C1
Ethisterone SCHEMBL606819 0.83 LMNA (1.00) SHBGLMNASMN1; SMN2TSHRNR3C1
Ethisterone SCHEMBL16691330 0.83 LMNA (1.00) SHBGLMNASMN1; SMN2TSHRNR3C1
Ethisterone SCHEMBL16864523 0.83 LMNA (1.00) SHBGLMNASMN1; SMN2TSHRNR3C1
Ethisterone SCHEMBL14433089 0.83 LMNA (1.00) SHBGLMNASMN1; SMN2TSHRNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0152429-B1 PROGESTATIONALLY ACTIVE STEROIDS RESEARCH TRIANGLE INSTITUTE (US) 1989-10-11 — — EP claimed
EP-0152429-A4 PROGESTATIONALLY ACTIVE STEROIDS. RES TRIANGLE INST (US) 1985-12-05 — — EP claimed
EP-0152429-A1 PROGESTATIONALLY ACTIVE STEROIDS. RES TRIANGLE INST (US) 1985-08-28 — — EP claimed
US-4512986-A FERTILITY CONTROL RESEARCH TRIANGLE INSTITUTE (US) 1985-04-23 — — US claimed
WO-1985000609-A1 PROGESTATIONALLY ACTIVE STEROIDS RESEARCH TRIANGLE INSTITUTE (US) 1985-02-14 — — WO claimed
EP-0152429-B1 PROGESTATIONALLY ACTIVE STEROIDS RESEARCH TRIANGLE INSTITUTE (US) 1989-10-11 — — EP disclosed
EP-0152429-A4 PROGESTATIONALLY ACTIVE STEROIDS. RES TRIANGLE INST (US) 1985-12-05 — — EP disclosed
EP-0152429-A1 PROGESTATIONALLY ACTIVE STEROIDS. RES TRIANGLE INST (US) 1985-08-28 — — EP disclosed
US-4512986-A FERTILITY CONTROL RESEARCH TRIANGLE INSTITUTE (US) 1985-04-23 — — US disclosed
WO-1985000609-A1 PROGESTATIONALLY ACTIVE STEROIDS RESEARCH TRIANGLE INSTITUTE (US) 1985-02-14 — — WO disclosed
Send feedback